SCHEMBL12440322

SCHEMBL12440322

CN1c2ccc(-c3ccc(-c4ccc(Cl)cc4)cn3)cc2CCC1CN1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 3/20 0.40
▸ PDK2 Q15119 3/20 0.40
▸ PDK3 Q15120 3/20 0.40
▸ PDK4 Q16654 3/20 0.40
▸ FFAR4 Q5NUL3 1/20 0.40
▸ MCHR1 Q99705 10/20 0.39
▸ CHRNB4 P30926 2/20 0.37
▸ CHRNA3 P32297 2/20 0.37
▸ CHRNB1 P11230 1/20 0.37
▸ CHRNB2 P17787 1/20 0.37
▸ CHRNB3 Q05901 1/20 0.37
▸ CYP2D6 P10635 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ CHRNA7 P36544 1/20 0.36
▸ MET P08581 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12441159 0.88 PDK1 (0.45) PDK1PDK2PDK3PDK4MCHR1
SCHEMBL12440634 0.86 CYP11B1 (0.38) PDK1PDK2PDK3PDK4MCHR1
SCHEMBL4503035 0.83 MCHR1 (0.55) MCHR1CYP2D6CHRM1HTR2A
SCHEMBL14767415 0.79 PDK1 (0.51) PDK1PDK2PDK3PDK4
SCHEMBL12440001 0.78 MCHR1 (0.44) MCHR1CYP2D6CHRM1HTR2AHRH3
SCHEMBL12440206 0.77 MCHR1 (0.37) FFAR4MCHR1CYP2D6CHRM1HTR2A
SCHEMBL12441153 0.73 MCHR1 (0.45) PDK1PDK2PDK3PDK4MCHR1
SCHEMBL4519018 0.72 MCHR1 (0.49) MCHR1CYP2D6CHRM1HTR2A
SCHEMBL12440750 0.71 HRH3 (0.43) MCHR1CHRM1HTR2AHTR2CKCNH2
SCHEMBL2326974 0.71 MCHR1 (0.49) MCHR1CYP2D6CHRM1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2357173-A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-08-17 — — EP disclosed
Send feedback